Evidence map›Paper›PMID 39273260›Full record

ArticleInternational journal of molecular sciences2024

Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.

Kylie Heitman, Seth Bollenbecker, Jordan Bradley, Brian Czaya, Abul Fajol, Sarah Madison Thomas, Qing Li, Svetlana Komarova, Stefanie Krick, Glenn C Rowe and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kylie HeitmanDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Seth BollenbeckerDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Jordan BradleyDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Brian CzayaDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-7888-2432
Abul FajolDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Sarah Madison ThomasDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Qing LiDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0003-4540-7915
Svetlana KomarovaDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Stefanie KrickDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-8284-6768
Glenn C RoweDivision of Cardiovascular Disease, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Matthew S AlexanderCenter for Exercise Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-7406-5171
Christian FaulDivision of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-7512-0977

Funding

Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)R01HL145528 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI FAUL, CHRISTIAN, WHITE, KENNETH E · 2019 to 2022
$2.4M
Targeting fibroblast growth factor receptors in cystic fibrosis-associated airway inflammation and mucociliary dysfunctionR01HL160911 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Stefanie Krick · 2022 to 2026
$2.1M
Hyperphosphatemia Contributes to Systemic Inflammation and Anemia in Chronic Kidney DiseaseR01DK125459 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FAUL, CHRISTIAN · 2020 to 2023
$1.5M
UAB KUH KURER25DK115353 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Jennifer S Pollock · 2018 to 2026
$1.0M
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in the Absence and Presence of Chronic Kidney DiseaseF31DK131914 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HEITMAN, KYLIE · 2022 to 2024
$143k
FGF23 contributes to anemia in Chronic Kidney Disease by elevating hepcidin productionF31DK117550 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CZAYA, BRIAN · 2018 to 2020
$102k
American Heart Association 24PRE1242192NHLBI NIH HHS R01 HL145528NHLBI NIH HHS R01 HL160911NIDDK NIH HHS F31 DK117550NIDDK NIH HHS F31 DK131914NIDDK NIH HHS R01 DK125459NIDDK NIH HHS R25 DK115353NIH HHS 1F31DK117550-22A1NIH HHS 1F31DK131914-24A1NIH HHS 1R01DK125459-24A1NIH HHS 1R01HL145528-24A1
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is associated with various pathologic changes, including elevations in serum phosphate levels (hyperphosphatemia), vascular calcification, and skeletal muscle atrophy. Elevated phosphate can damage vascular smooth muscle cells and cause vascular calcification. Here, we determined whether high phosphate can also affect skeletal muscle cells and whether hyperphosphatemia, in the context of CKD or by itself, is associated with skeletal muscle atrophy. As models of hyperphosphatemia with CKD, we studied mice receiving an adenine-rich diet for 14 weeks and mice with deletion of Collagen 4a3 (

Indexed as

HyperphosphatemiaMusclesMuscular AtrophyAdenineAnimalsAutoantigensCells, CulturedCollagen Type IVDietFemaleFibroblast Growth Factor-23Klotho ProteinsMaleMice, Inbred C57BLMuscle Fibers, SkeletalMuscle StrengthAdenineAutoantigensCollagen Type IVFibroblast Growth Factor-23Klotho ProteinsPhosphatestype IV collagen alpha3 chainchronic kidney diseasehyperphosphatemiaphosphatesarcopeniaskeletal muscle atrophy

Identifiers

PMID39273260
PMCPMC11395169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.